Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Targeted cancer therapies often cause serious skin problems that need careful management.

Sox9 is present in most canine skin tumors and may help understand stem cells' role in these cancers.

Skin aging is a complex process influenced by various factors, leading to wrinkles and sagging, and should be considered a disease due to its health impacts.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

Finasteride and SSRIs together increase impotence and low libido risk in men.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

A woman's hair turned white after taking a cancer drug called dasatinib.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

A 37-year-old male with severe skin and internal issues has a rare inherited skin condition called dystrophic epidermolysis bullosa.

Most Cochrane Skin Group reviews are helpful for improving dermatology practices, but some lack enough evidence for clinical recommendations.

Skin reactions from cancer treatments might predict how well the treatments work.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The document concludes that scalp conditions have various causes and can present in many different ways.